美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA211232"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
60760-773-60 60760-773 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20230209 N/A ANDA ANDA211232 ST. MARY'S MEDICAL PARK PHARMACY ETHACRYNIC ACID 25 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (60760-773-60)
60760-773-30 60760-773 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20230209 N/A ANDA ANDA211232 ST. MARY'S MEDICAL PARK PHARMACY ETHACRYNIC ACID 25 mg/1 30 TABLET in 1 BOTTLE, PLASTIC (60760-773-30)
72162-2257-1 72162-2257 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20240223 N/A ANDA ANDA211232 Bryant Ranch Prepack ETHACRYNIC ACID 25 mg/1 100 TABLET in 1 BOTTLE (72162-2257-1)
50228-334-01 50228-334 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20190827 N/A ANDA ANDA211232 ScieGen Pharmaceuticals Inc ETHACRYNIC ACID 25 mg/1 1000 TABLET in 1 BOTTLE (50228-334-01)
50228-334-10 50228-334 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20190827 N/A ANDA ANDA211232 ScieGen Pharmaceuticals Inc ETHACRYNIC ACID 25 mg/1 100 TABLET in 1 BOTTLE (50228-334-10)
50228-334-30 50228-334 HUMAN PRESCRIPTION DRUG Ethacrynic Acid Ethacrynic Acid TABLET ORAL 20190827 N/A ANDA ANDA211232 ScieGen Pharmaceuticals Inc ETHACRYNIC ACID 25 mg/1 30 TABLET in 1 BOTTLE (50228-334-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase